Strattera Side Effects in the First Month: What to Expect

Most people starting Strattera expect side effects to feel like a stimulant: fast in, fast out. Atomoxetine does not work that way. The side effects can show up early while the actual ADHD benefit is still weeks away, which is exactly the gap that causes people to give up before the medication has had a chance to help.

What This Post Covers

• Why Strattera Works on a Different Timeline Than Stimulants
• The First One to Two Weeks: Appetite, Nausea, and Dry Mouth
• Sleep, Energy, and Heart Rate Changes to Expect
• Mood and Behavior Changes That Need Closer Attention
• Strattera Side Effect Timeline at a Glance
• Why the Benefit Takes Longer to Show Up Than the Side Effects
• When to Call Your Prescriber Right Away
• How Siggy Tracks the First Month
• Bottom Line

Why Strattera Works on a Different Timeline Than Stimulants

Strattera (atomoxetine) is a selective norepinephrine reuptake inhibitor, not a stimulant. Stimulants raise dopamine and produce a noticeable effect within hours. Atomoxetine instead increases norepinephrine availability in the prefrontal cortex, and that circuit needs sustained, steady drug levels before attention and impulse control measurably improve.

According to a 2015 clinical and pharmacological review in the Journal of Psychopharmacology, atomoxetine can produce an initial effect within one to two weeks, but response continues to build incrementally for up to 24 weeks or longer in some patients. That is a fundamentally different pattern than a stimulant, and it means the first month is mostly about tolerating early side effects, not judging whether the medication works.

The First One to Two Weeks: Appetite, Nausea, and Dry Mouth

Per the FDA-approved prescribing information for Strattera, the most common adverse reactions in adults are constipation, dry mouth, nausea, decreased appetite, dizziness, erectile dysfunction, and urinary hesitation, each occurring in at least 5% of patients and at roughly twice the rate seen with placebo. In children and adolescents, the most common early reactions are nausea, vomiting, fatigue, decreased appetite, abdominal pain, and somnolence.

Decreased appetite deserves particular attention. According to Strattera’s original FDA prescribing information, atomoxetine-treated patients lost an average of 0.4 kg during acute treatment studies, while placebo patients gained an average of 1.5 kg over the same period, with weight loss occurring in a dose-dependent pattern. For most patients, appetite partially recovers after the first few weeks, but growth and weight should still be tracked over time, especially in children.

Taking the dose with food can reduce nausea. Splitting a single daily dose into a morning and afternoon dose can also ease both appetite suppression and stomach upset for some patients, though any dosing change should go through your prescriber first.

Sleep, Energy, and Heart Rate Changes to Expect

Sleep effects can go in either direction. Some patients feel more fatigued, particularly in the first couple of weeks, while others notice difficulty falling asleep. Because atomoxetine has a roughly 24-hour effect from a single dose, adjusting whether it is taken in the morning or evening is often the first lever a prescriber will try before considering a dose change.

In FDA prescribing information covering Strattera’s cardiovascular data, adult placebo-controlled trials found atomoxetine was associated with a mean heart rate increase of about 5 beats per minute and small increases in systolic and diastolic blood pressure compared with placebo, with tachycardia identified as an adverse reaction in 1.5% of adult patients. These changes are usually modest, but they are the reason your prescriber checks heart rate and blood pressure before starting treatment, after dose increases, and periodically afterward.

Mood and Behavior Changes That Need Closer Attention

Atomoxetine carries an FDA boxed warning about increased risk of suicidal thoughts in children and adolescents. According to Strattera’s FDA-approved medication guide, the risk of suicidal thoughts and actions is highest within the first few months of treatment or when the dose is changed, which is why close monitoring during this window matters more than at any other point in treatment.

Separately, some patients, particularly children without a prior history of psychiatric illness, can experience treatment-emergent irritability, aggression, or mood swings. These are not effects to wait out silently. Report any new or worsening mood or behavior change to your prescriber as soon as you notice it, rather than at the next scheduled visit.

Strattera Side Effect Timeline at a Glance

Because Strattera’s side effects and benefits move on different clocks, it helps to see them side by side.

Effect	Typical Onset	Typical Pattern	What To Do
Decreased appetite, nausea	Days 1 to 14	Often eases, sometimes persists	Take with food, track weight
Dry mouth, dizziness	Days 1 to 14	Usually mild and transient	Hydration, report if severe
Fatigue or sleep changes	Weeks 1 to 4	Improves for most patients	Adjust dose timing with prescriber
Heart rate, blood pressure rise	Ongoing	Small, steady increase	Baseline and periodic monitoring
ADHD symptom improvement	Weeks 4 to 8, up to 24	Builds gradually	Continue as directed, do not judge early

Why the Benefit Takes Longer to Show Up Than the Side Effects

This mismatch, side effects in week one, meaningful benefit at week four to eight, is the single biggest reason people stop atomoxetine before it has a fair chance to work. The medication is doing something during those early weeks even though it does not feel like it yet: norepinephrine transporter blockade is occurring immediately, but the downstream adaptation in prefrontal circuits that produces attention and impulse control benefits takes considerably longer to complete.

Patients and caregivers who understand this timeline in advance are better positioned to tolerate an uncomfortable first few weeks instead of concluding early that the medication failed.

When to Call Your Prescriber Right Away

Some symptoms should never be treated as something to wait out. Call your prescriber, or seek emergency care, for any of the following:

New or worsening thoughts of self-harm or suicide, or a mood change that feels qualitatively different from baseline. If you or someone you know is in crisis, call or text 988 (Suicide and Crisis Lifeline) or call 911.

A racing or irregular heartbeat, chest pain, fainting, or signs of unusually high blood pressure.

Yellowing of the skin or eyes, dark urine, or right upper abdominal pain, which can signal rare but serious liver injury.

A painful or prolonged erection, which requires prompt medical attention.

How Siggy Tracks the First Month

The hardest part of a slow-onset medication like Strattera is staying with it through weeks that feel like all cost and no benefit. That is where daily check-ins matter most. When appetite loss, fatigue, or mood changes are logged as they happen instead of recalled weeks later at an appointment, your care team can see the actual trajectory, not just a snapshot.

That kind of continuity is the difference between a patient who stops in week two because nothing feels different, and one who reaches week six with the data to show their prescriber exactly what happened along the way. Start your anonymous intake to see how a clinician-reviewed plan and ongoing check-ins can support you through a slower-acting medication like atomoxetine.

Bottom Line

Strattera side effects and Strattera benefits do not arrive on the same schedule. The early weeks bring appetite changes, nausea, dry mouth, and sometimes fatigue, most of which ease as the body adjusts. The ADHD benefit itself typically takes four to eight weeks to become clear, and some patients continue to improve for months. Knowing that gap exists ahead of time, and tracking side effects as they happen rather than guessing at the next appointment, is what makes it possible to stay with the medication long enough to find out if it works.